The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)December 17, 2025 — President Donald Trump is expected to announce a plan that could shift cannabis from Schedule I to Schedule III under federal drug law, a change that would, for the first time, formally acknowledge cannabis as having accepted medical use in the U. S.
December 17, 2025 — Disseminated on behalf of Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) and may include paid advertisements.
December 17, 2025 — Safe and Green Holdings (NASDAQ: SGBX), a diversified holding company, is set to close 2025 with a Dec. 29 shareholder meeting centered on defining the company’s next phase in the U.
December 17, 2025 — Disseminated on behalf of Search Minerals Inc. (TSX.
December 17, 2025 — HeartBeam (NASDAQ: BEAT), a medical-technology company developing advanced electrocardiogram solutions, was featured in a recent article that discussed its recognition as a Global IP and Technology Leader in Portable Cardiac Diagnostics by PatentVest’s “Total Cardiac Intelligence” report. “The company ranked second worldwide in 12-lead ECG innovation among 243 firms analyzed, trailing only GE Healthcare.
December 17, 2025 — RXR Capital announced the closing of a $4. 3 million receivables-backed financing for a Northeast-based operator of 11 bodega and neighborhood convenience store locations.
December 17, 2025 — Knightscope (NASDAQ: KSCP) announced it has exceeded another $1 million milestone in new sales, client renewals and expansions, following the release of its 2025 Letter from the CEO outlining the vision for the nation’s first Autonomous Security Force. The Company reported continued momentum across both Emergency Communication Devices and Autonomous Security Robots, including 39 new ECD sales across government, education and healthcare markets, more than 60 ECD maintenance renewals, eight new Machine-as-a-Service subscriptions, three new Risk & Threat premium accounts, and seven ASR subscription renewals, reinforcing the strength and scalability of its subscription-based security technology platform.
December 17, 2025 — This article has been disseminated on behalf of Powermax Minerals Inc. and may include paid advertising.
December 17, 2025 — Earlier this year, Forward Industries pivoted toward digital asset management, transforming into the world’s largest Solana-based DAT. The Oak Ridge report observes a notable expansion in institutional activity even amid the downturn in the crypto market.
December 17, 2025 — Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on treatments for rare diseases with unmet medical need, reported extended results from its ongoing Phase 2a trial evaluating SGX302 (synthetic hypericin) for mild-to-moderate psoriasis, including outcomes from an additional cohort treated with an optimized topical gel formulation. The gel was well tolerated with no drug-related adverse events and demonstrated improvements across multiple clinical and quality-of-life measures, including Investigator Global Assessment and Psoriasis Area and Severity Index scores, with results comparable to or exceeding those observed with the prior ointment formulation, supporting continued development of SGX302 as a potential non-carcinogenic, non-mutagenic therapeutic option for psoriasis.
December 17, 2025 — CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for primary and metastatic cancers of the brain and central nervous system, reported a leadership transition under which John Climaco has stepped down as chief executive officer and Rami Levin, MBA, has been appointed president and chief executive officer, effective Jan. 1, 2026.
December 17, 2025 — Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on cancer therapeutics, has been named a winner of the 2025 Clinical Trials Arena Excellence Awards, receiving the Research and Development Award for Advanced Prostate Cancer. The recognition highlights the Company’s work advancing ENV-105 (carotuximab), a first-in-class CD105-targeting monoclonal antibody being developed to address treatment resistance in metastatic castration-resistant prostate cancer, including positive interim safety and efficacy results from a Phase 2 randomized clinical trial evaluating ENV-105 in combination with apalutamide.
December 17, 2025 — This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX) OTC: MAXXF) (FRANKFURT: 89N) has closed a non-brokered private placement for gross proceeds of $5 million (CDN), marking the first large investment by a Vietnam-based company in Saskatchewan and forming part of a strategic partnership with Bitexco affiliate Big Energy.
December 17, 2025 — Artificial intelligence is quickly becoming part of everyday life, and health care is no exception. Under a major bill pushed by U.
December 17, 2025 — Research indicates that the advantages of nanoparticle delivery in pharma are significant Oncotelic Therapeutics has advanced nanoparticle-based delivery strategies through its joint venture entity, involving its Deciparticle platform Oncotelic is leveraging the very concepts of nanoparticle-mediated delivery in a real-world clinical context In the evolving landscape of pharmaceutical innovation, nanoparticles are rapidly transforming how we think about drug delivery, and Oncotelic Therapeutics (OTCQB: OTLC) is placing itself at the heart of that transformation by applying ultra-small carrier technologies to elevate existing cancer therapies. The company is pioneering how nanotechnology can enhance bioavailability, precision targeting and therapeutic performance of anticancer compounds.
December 17, 2025 — Xeriant (OTCQB: XERI), a technology company focused on the discovery, development and commercialization of advanced and sustainable materials, has engaged IBN to support its corporate communications strategy. Xeriant operates as a strategic holding company with exposure to next-generation aerospace and advanced materials technologies, including its DUREVER(TM) advanced materials program led by NEXBOARD(TM), a patent-pending composite construction panel made from recycled plastic and fiber waste and enhanced with proprietary nanotechnology-based fire retardants, which is being developed as a high-performance alternative to traditional building materials and is undergoing testing and certification.
December 17, 2025 — Scientists at Northwestern Medicine have discovered a biological marker that predicts which cancer patients are more resistant to immunotherapy. Dubbed USP22, the marker also points to a potential treatment target for non-responders.
December 17, 2025 — Prices of copper have soared in 2025, with the metal reaching several record highs along the way. As the year comes to an end, several analysts are forecasting that this rally could carry on into 2026 fueled by a number of factors.
December 16, 2025 — Ohio Governor Mike DeWine stated that he plans to sign legislation that would prohibit the sale of intoxicating hemp products and revise parts of the state’s recreational cannabis law that voters approved in 2023. The measure also introduces new criminal provisions related to cannabis possession and sales.
December 16, 2025 — Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising.